Technical Specifications

• CAS Number: 189691-06-3
  
• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
  
• Molecular Weight: 1025.2 g/mol
  
• PubChem ID: 6918280
  
• Purity: ≥99% (HPLC tested)
  
• Form: Lyophilized powder
• Synthesis Method: Solid-phase peptide synthesis
  

Analytical & Testing

Each batch of PT-141 (Bremelanotide) undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis to verify purity, identity, and analytical consistency. A corresponding Certificate of Analysis (COA) is available for each batch.

Handling & Storage

This compound should be handled by qualified professionals in controlled laboratory environments. Proper storage conditions should be maintained to preserve compound stability and structural integrity.

Research Context

In preclinical and laboratory research models, PT-141 has been examined across neurological, endocrine, and cellular systems. Research focus includes:

• Melanocortin receptor (MC3R, MC4R) interaction models
• Central nervous system (CNS) signaling pathways
• Neuroendocrine pathway interactions
• Cellular signaling mechanisms

These observations are limited to controlled experimental environments and support ongoing laboratory investigations.

Research Application Scope

PT-141 (Bremelanotide) continues to be evaluated for its relevance in experimental biology, particularly within studies involving melanocortin receptor pharmacology, neuroendocrine signaling, and biochemical pathway analysis.

Use Statement

For laboratory research use only. Intended strictly for in vitro research applications.

Disclaimer

All products currently listed on this site are for research purposes ONLY.